GTx, Inc. Announces the Appointments of Andrew M. Clarkson and J. Kenneth Glass to its Board of Directors
02 Mars 2004 - 2:30PM
PR Newswire (US)
GTx, Inc. Announces the Appointments of Andrew M. Clarkson and J.
Kenneth Glass to its Board of Directors MEMPHIS, Tenn., March 2
/PRNewswire-FirstCall/ -- Mitchell Steiner, M.D., F.A.C.S., Vice
Chairman and CEO of GTx, Inc. today announced the appointments of
Andrew M. Clarkson and J. Kenneth Glass to the Company's Board of
Directors. Mr. Clarkson will serve as Chairman of the Board's Audit
Committee and will be a member of the Board's Nominating and
Corporate Governance Committee. Subsequent to working in senior
financial positions at General Foods Corporation and as Vice
President/Treasurer of F.W. Woolworth, Mr. Clarkson became Chief
Financial Officer and a Board Director of Malone & Hyde, Inc.,
where he played a pivotal role in taking Malone & Hyde private.
This first-ever cash tender offer leveraged buyout resulted in the
formation of AutoZone, Inc., an auto parts chain that subsequently
became a NYSE-listed company in 1991 and today comprises more than
3,000 stores with sales over $5billion. Mr. Clarkson remained on
the Board of AutoZone, Inc. through November 2001. Mr. Clarkson
graduated from Oxford University, attended McGill University and
earned an MBA from Harvard Business School. He currently serves on
the Boards of Amphenol Corporation, Royal Furniture and TruckPro,
Inc., and is actively involved with not-for-profit organizations
through board positions at the Memphis Arts Council, The Lifeblood
Foundation, The New Canaan Elder Care Council and the Jeniam
Foundation. Mr. Glass is currently Chairman, President and Chief
Executive Officer of First Tennessee National Corporation and First
Tennessee Bank, N.A. (NYSE:FTN), one of the nation's 50 largest
bank holding companies with total assets of $24.5 billion. Mr.
Glass will serve on both the Board's Audit Committee and
Compensation Committee. Mr. Glass brings extensive financial
expertise to the Board, having worked in a range of capacities at
First Tennessee National Corporation and First Tennessee Bank, N.A.
for the past 30 years. Prior to joining First Tennessee, Mr. Glass
served as an audit manager and CPA for Arthur Andersen and Company.
Mr. Glass received his B.A. in Accounting from Harding University
and graduated from Harvard Business School's Advanced Management
Program. He currently serves on the Board of Directors for FedEx
Corporation. About GTx, Inc. GTx is a biopharmaceutical company
dedicated to the discovery, development and commercialization of
therapeutics primarily related to the treatment of serious men's
health conditions. GTx's drug discovery and development programs
are focused on small molecules that selectively modulate the
effects of estrogens and androgens. GTx currently has two product
candidates that are in human clinical trials. The company is
developing Acapodene, its most advanced product candidate, through
clinical trials for two separate indications: (1) a Phase IIb
clinical trial for the reduction in the incidence of prostate
cancer in men with precancerous prostate lesions and (2) a pivotal
Phase III clinical trial for the treatment of serious side effects
of advanced prostate cancer therapy. GTx is developing its second
product candidate, Andarine, for the treatment of muscle wasting
weight loss, or cachexia, that occurs from various types of cancer.
CONTACT: Carney Duntsch Manager, Corporate Communications GTx, Inc.
901-523-9700 ext. 170 DATASOURCE: GTx, Inc. CONTACT: Carney
Duntsch, Manager, Corporate Communications of GTx, Inc.,
+1-901-523-9700, ext. 170
Copyright
First Tenn Natl (NYSE:FTN)
Graphique Historique de l'Action
De Avr 2024 à Mai 2024
First Tenn Natl (NYSE:FTN)
Graphique Historique de l'Action
De Mai 2023 à Mai 2024
Real-Time news about First Tenn Natl Cp (New York Stock Exchange): 0 recent articles
Plus d'articles sur First Tenn Natl Cp